
Loading, please wait...

Loading, please wait...

Health officials in Colorado recently confirmed that an adult died from a hantavirus infection. This case does not involve the respiratory illness outbreak currently affecting a cruise ship in the Atlantic. Instead, the death involves a strain that regularly occurs in Colorado during this season. Consequently, authorities are investigating the specific source of exposure for this individual. Hantavirus infection symptoms often appear after contact with rodent droppings, urine, or saliva.
The incubation period for this virus typically lasts between one and six weeks. Initially, patients experience a prodromal phase that mimics common viral illnesses. These early symptoms include fatigue, fever, and muscle aches, particularly in the large muscle groups. Moreover, about half of those infected develop headaches, dizziness, and gastrointestinal issues such as nausea and abdominal pain. Therefore, early diagnosis remains challenging because the signs often resemble influenza or other respiratory infections.
As the disease progresses, late-stage symptoms usually emerge four to ten days after the initial phase. Patients may experience coughing, severe shortness of breath, and a feeling of tightness in the chest. These symptoms indicate that the lungs are filling with fluid. This condition, known as Hantavirus Pulmonary Syndrome (HPS), has a high mortality rate of approximately 38%. However, rapid medical intervention can improve the chances of survival for critically ill patients.
In a separate incident, the World Health Organization reported a cluster of severe respiratory illnesses aboard the MV Hondius cruise ship. This outbreak involved the Andes virus strain of hantavirus. Unlike most North American strains, the Andes virus can transmit between humans through prolonged, close contact. To date, three passengers on the liner have died. Additionally, there are eight confirmed and two probable cases among the crew and passengers. Consequently, health authorities across 23 countries are currently monitoring contacts and repatriated passengers.
Rodents serve as the primary reservoir for hantaviruses. Most people contract the virus by inhaling airborne particles from disturbed rodent nesting materials. Furthermore, direct contact with contaminated surfaces or rodent bites can also lead to infection. To reduce risk, health officials recommend cleaning infested areas using disinfectants rather than dry sweeping. Similarly, sealing entry points in homes prevents rodents from establishing nests in living spaces. Therefore, maintaining a rodent-free environment is the most effective way to prevent this deadly disease.
Q1: Is hantavirus always transmitted by rodents?
While most hantaviruses spread through contact with rodent excreta, the Andes strain can transmit between people in rare, close-contact scenarios.
Q2: How long does it take for symptoms to appear?
Symptoms usually develop within one to eight weeks after exposure, though the typical range is two to four weeks.
Q3: Can hantavirus be cured with antibiotics?
No, hantavirus is a viral infection and does not respond to antibiotics. Treatment focuses on supportive care and managing respiratory distress in intensive care settings.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A Colorado death and a cruise ship cluster highlight hantavirus risks. Learn about hantavirus infection symptoms, transmission, and the Andes virus strain....
3 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today